ADNT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Adient PLC (ADNT) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown some financial improvement and hedge funds are increasing their positions, the lack of significant positive catalysts, recent analyst downgrades, and a weak technical outlook suggest it is better to hold off on investing right now.
The MACD is positive and expanding, indicating some bullish momentum, but the RSI is neutral at 51.287, showing no clear trend. The stock is trading near its pivot level of 20.442, with resistance at 21.427 and support at 19.456. Moving averages are converging, suggesting indecision in the market.
Hedge funds are significantly increasing their positions, with a 230.21% increase in buying over the last quarter. The company reported a 4.26% YoY revenue increase in Q1 2026, and Deutsche Bank sees a compelling turnaround story with potential benefits from automakers onshoring production in the U.S.
Analysts have recently lowered price targets, with concerns over weaker China LVP, Iran conflict risks, and FX headwinds. The stock has declined 1.16% in the regular market and 0.24% in pre-market trading. Net income and EPS remain negative, with no significant improvement YoY. No recent news or significant insider trading activity provides additional confidence.
In Q1 2026, revenue increased by 4.26% YoY to $3.644 billion. However, net income and EPS remained negative at -$22 million and -$0.28, respectively. Gross margin improved slightly to 6.26%, up 1.29% YoY.
Recent analyst ratings are mixed to negative. Deutsche Bank upgraded the stock to Buy with a $33 target, citing a turnaround story. However, Wells Fargo and Barclays lowered their price targets to $28 and $26, respectively, citing weaker full-year drivers and risks in China and Iran. BofA reinstated coverage with an Underperform rating and a $22 target, highlighting profitability headwinds.
